Zacks Investment Research on MSN7h
Why the Market Dipped But Merck (MRK) Gained Today
In the latest trading session, Merck (MRK) closed at $89.23, marking a +1.86% move from the previous day. This move outpaced the S&P 500's daily loss of 1.97%. Meanwhile, the Dow experienced a drop of ...
In the assessment of 12-month price targets, analysts unveil insights for Lexicon Pharmaceuticals, presenting an average ...
Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for sector-focused investors ...
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
In the assessment of 12-month price targets, analysts unveil insights for X4 Pharmaceuticals, presenting an average target of ...
We think CR Pharma has a weaker financial position compared with the top three medical distributors. Similar to other pharmaceutical distributors, accounts receivable make up a large portion of its ...
President Trump said Wednesday he was placing 25% tariffs on auto imports, a move that the White House claims would foster ...
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced ...
Gain insights into Paysign, Inc.'s Q4 2024 performance, driven by 212% growth in patient affordability revenue.
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...